EXHIBIT 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-261997 and 333-229432) and Form S-3 (File No. 333-251988) of AgeX Therapeutics, Inc. of our report dated March 31, 2021, relating to the consolidated financial statements of AgeX Therapeutics, Inc., which appears in this Annual Report on Form 10-K.

/s/ OUM & CO. LLP

San Francisco, California

March 29, 2022